216 related articles for article (PubMed ID: 3573825)
21. Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.
Vitale G; Ciccarelli A; Caraglia M; Galderisi M; Rossi R; Del Prete S; Abbruzzese A; Lupoli G
Clin Chem; 2002 Sep; 48(9):1505-10. PubMed ID: 12194927
[TBL] [Abstract][Full Text] [Related]
22. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
23. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging.
Wells SA; Baylin SB; Gann DS; Farrell RE; Dilley WG; Preissig SH; Linehan WM; Cooper CW
Ann Surg; 1978 Sep; 188(3):377-83. PubMed ID: 686900
[TBL] [Abstract][Full Text] [Related]
24. Stimulation tests for diagnosis of medullary thyroid carcinoma.
Sizemore GW; Go VL
Mayo Clin Proc; 1975 Feb; 50(2):53-6. PubMed ID: 1117754
[TBL] [Abstract][Full Text] [Related]
25. Urine calcitonin as a test for medullary thyroid cancer: a new screening procedure.
Silva OL; Snider RH; Moore CF; Becker KL
Ann Surg; 1979 Mar; 189(3):269-74. PubMed ID: 426557
[TBL] [Abstract][Full Text] [Related]
26. Clinical performance of an extraction calcitonin radioimmunoassay.
Kao PC; Gharib H
Mayo Clin Proc; 1993 Dec; 68(12):1165-70. PubMed ID: 8246617
[TBL] [Abstract][Full Text] [Related]
27. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
28. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
Zink A; Blind E; Raue F
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
[TBL] [Abstract][Full Text] [Related]
29. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
30. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
31. [Tests of stimulation of calcitonin secretion. Value in medullary cancer of the thyroid].
Milhaud G; Ribeiro FM; Calmettes C; Taboulet J; Coutris G; Moukhtar MS
Nouv Presse Med; 1975 Jun; 4(24):1793-5. PubMed ID: 1099542
[TBL] [Abstract][Full Text] [Related]
32. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
33. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of new assays for determination of serum calcitonin concentrations.
Weissel M; Kainz H; Tyl E; Ogunyemi E; Woloszczuk W
Acta Endocrinol (Copenh); 1991 May; 124(5):540-4. PubMed ID: 2028712
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
Roos BA; Deftos LJ; Roberts G; Wilson P; Bundy L
J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
[TBL] [Abstract][Full Text] [Related]
37. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
Machens A; Hauptmann S; Dralle H
J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
[TBL] [Abstract][Full Text] [Related]
38. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
40. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
